• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 10/16/24: Coverage from Access Insights 2024, Racial Inequity in Lung Cancer Screening & more

News
Article

The latest news for pharma industry insiders.

Access Insights 2024: Playing the Chess Endgame: Healthcare Policies Targeting Drug Commercialization

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses breakout session and the impact of healthcare policies on manufacturing and commercialization.

Study Reveals Racial Inequity in Lung Cancer Screening Based on Pack-Year Smoking History

A collaboration between researchers at Massachusetts General Hospital, Boston University, Vanderbilt University Medical Center and the University of Chicago Hospital, explored whether how using a smoking duration cutoff instead of a pack-year one to determine lung cancer screening eligibility would affect the populations eligible for lung cancer screening.

Amazon, Databricks Strike Five-Year Deal Around AI Chips

Databricks will tap Amazon’s Trainium chips to power services for building AI systems, a move that could cut costs for businesses.

AllazoHealth Appoints Three New Advisory Board Members Amid Product Expansions

AllazoHealth, the pioneer in driving therapy initiation, adherence, and health outcomes with artificial intelligence (AI)-powered personalization, today announced that Joy S. Neely, Nagaraja Srivatsan, and Kenneth Ziegler have joined its advisory board. The three executives have extensive backgrounds in life sciences, technology, and enterprise growth strategies, and will provide valuable insights to AllazoHealth as the company initiates plans for product expansions and growth.

Spark Growth on LinkedIn

"With ubiquitous access to health information about diseases, symptoms, and treatment options through digital channels such as websites, social media and health apps, this patient empowerment is demanding a new level of engagement between patients and healthcare professionals."

This is why having a patient-centric approach to your brand's marketing funnel is important!

Read more insights from Claus Zieler in this Pharmaceutical Executive interview: https://lnkd.in/g28uxynu

#GrowthMarketing #SocialMedia #HealthcareMarketing #PharmaMarketing

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs